News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celladon Corporation and SIRO Clinpharm (India) Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"



5/10/2013 7:30:10 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MUMBAI, May 10, 2013 /PRNewswire/ --

Analysis of Recurrent Heart Failure Hospitalizations in Presence of Informative Censoring - Application of Joint Frailty Model

Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that it will present analysis methods for the MYDICAR development program at an upcoming conference.

Help employers find you! Check out all the jobs and post your resume.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES